Synchron is a clinical-stage neurotechnology company developing an implantable brain-computer interface (BCI) called Stentrode™. Designed for patients with severe paralysis, the device is implanted endovascularly via the jugular vein without open brain surgery. It restores motor signaling to enable control of digital devices and enhance autonomy. Utilizing artificial intelligence, hardware, and software, Synchron aims to restore communication and independence for individuals with motor impairments due to conditions like stroke or spinal cord injury. The technology is currently assessed in clinical trials in the USA and Australia.